93 related articles for article (PubMed ID: 1852008)
1. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.
Tamm I; Cardinale I; Murphy JS
Proc Natl Acad Sci U S A; 1991 May; 88(10):4414-8. PubMed ID: 1852008
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I; Cardinale I; Krueger J; Murphy JS; May LT; Sehgal PB
J Exp Med; 1989 Nov; 170(5):1649-69. PubMed ID: 2553849
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 enhances motility of breast carcinoma cells.
Sehgal PB; Tamm I
EXS; 1991; 59():178-93. PubMed ID: 1655518
[TBL] [Abstract][Full Text] [Related]
4. Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.
Tamm I; Kikuchi T; Cardinale I; Krueger JG
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3329-33. PubMed ID: 7512730
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells.
Tamm I; Cardinale I; Sehgal PB
Cytokine; 1991 May; 3(3):212-23. PubMed ID: 1653054
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.
Tamm I; Cardinale I; Kikuchi T; Krueger JG
Proc Natl Acad Sci U S A; 1994 May; 91(10):4338-42. PubMed ID: 8183909
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 enhances motility of breast cancer cells.
Sehgal PB; Tamm I
Cancer Invest; 1990; 8(6):661-3. PubMed ID: 1963346
[No Abstract] [Full Text] [Related]
8. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
9. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
Chen L; Shulman LM; Revel M
J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6.
Verhasselt B; Van Damme J; van Larebeke N; Put W; Bracke M; De Potter C; Mareel M
Eur J Cell Biol; 1992 Dec; 59(2):449-57. PubMed ID: 1493810
[TBL] [Abstract][Full Text] [Related]
11. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicity.
Reiter Z; Chen L; Revel M; Rubinstein M
Lymphokine Cytokine Res; 1992 Jun; 11(3):175-81. PubMed ID: 1327193
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
14. [Relation of cell proliferation to regression with special reference to epithelial tumors].
Stifns R; Klotz D
Verh Dtsch Ges Pathol; 1985; 69():274-8. PubMed ID: 3006382
[No Abstract] [Full Text] [Related]
15. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
Asgeirsson KS; Olafsdóttir K; Jónasson JG; Ogmundsdóttir HM
Cytokine; 1998 Sep; 10(9):720-8. PubMed ID: 9770334
[TBL] [Abstract][Full Text] [Related]
16. Adhesion, growth and cytoskeletal characteristics of 8701-BC breast carcinoma cells cultured in the presence of type V collagen.
Luparello C; Schillaci R; Pucci-Minafra I; Minafra S
Eur J Cancer; 1990 Mar; 26(3):231-40. PubMed ID: 2162687
[TBL] [Abstract][Full Text] [Related]
17. Growth-stimulating activity of interleukin 6 on human mammary epithelial cells transfected with the int-2 gene.
Basolo F; Calvo S; Fiore L; Conaldi PG; Falcone V; Toniolo A
Cancer Res; 1993 Jul; 53(13):2957-60. PubMed ID: 8100482
[TBL] [Abstract][Full Text] [Related]
18. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
19. Modelling the early growth of ductal carcinoma in situ of the breast.
Franks SJ; Byrne HM; King JR; Underwood JC; Lewis CE
J Math Biol; 2003 Nov; 47(5):424-52. PubMed ID: 14605857
[TBL] [Abstract][Full Text] [Related]
20. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
